41 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:19pm
information and expose us to liability, which could adversely affect our business and our reputation;
our existing strategic partnerships are important
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
and expose us to liability, which could adversely affect our business and our reputation; and we are exposed to foreign currency and currency fluctuation … significantly;
we may be subject to litigation or product liability claims; and
our reputation may suffer.
Any of these events could prevent us or our
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:15pm
reputation;
our existing strategic partnerships are important to our business, and future strategic partnerships may also be important to us; if we
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:12pm
information and expose us to liability, which could adversely affect our business and our reputation;
our existing strategic partnerships are important
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
and expose us to liability, which could adversely affect our business and our reputation; and we are exposed to foreign currency and currency fluctuation … significantly;
we may be subject to litigation or product liability claims; and
our reputation may suffer.
Any of these events could prevent us or our
424B3
pdvve7j
13 Jun 24
Prospectus supplement
4:10pm
6-K
EX-99.2
dxe sfjnba
16 May 24
Condensed Interim Consolidated Financial Statements
6:45pm
6-K
EX-99.2
fki0g
15 Nov 23
Condensed Interim Consolidated Financial Statements
9:30pm
424B3
6nh56mwrw6jm 35
25 Aug 23
Prospectus supplement
6:00am
424B3
2185jbyx5 m1pj
25 Aug 23
Prospectus supplement
6:00am
6-K
EX-99.2
a38hrv
15 Aug 23
Condensed Interim Consolidated Financial Statements
6:00am
6-K
EX-99.2
hryyxcfno4dvhwyi
16 May 23
Condensed Interim Consolidated Financial Statements
9:32am
6-K
EX-99.3
w9wnn5 2yb2
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.2
l8shfp xasci4
3 Apr 23
Consolidated Financial Statements
6:05am
424B3
17etycmy94vw2arw h6
14 Nov 22
Prospectus supplement
1:51pm